How Google plans to detect heart attacks and cancer
Google is developing a pill containing nanoparticles and a wristband to diagnose diseases in the body
Google is developing a pill containing nanoparticles that can roam the human body to diagnose cancer or an impending heart attack.
The search giant announced its plans at a tech conference yesterday in a bid to find new partners for the project.
Dr Andrew Conrad, a molecular biologist who previously developed a cheap HIV test, is leading the project at the company's experimental research lab Google X, which has previously worked on self-driving cars and contact lenses for patients with diabetes. So how would the new technology work and does it pose any risks?
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What is a nanoparticle?
It is a tiny piece of matter that can occur naturally or by design. The particles are so small they are measured in nanometres, one of which is one billionth of a metre, or one millionth of a millimetre.
What would Google use them for?
In theory, the user would ingest the nanoparticles, which would be programmed to attach themselves to any cancerous cells or fatty plaques that might cause a heart attack or stroke. Another type of nanoparticle might monitor chemicals in the blood to detect problems such as kidney disease, which is linked to high levels of potassium in the blood. Google wants to develop software, worn as a wristband, that could take readings from the nanoparticles via light and radio waves and make a diagnosis. Dr Conrad says the company's "dream" is that the system will be used for every test normally carried out by a doctor.
How long before it works?
Will Oremus at Slate says the word "dream" seems appropriate. "Intriguing as the concept is, there's an awful lot that still has to go right for Google to pull off something like this." The company has to develop the technology, but also faces a much higher regulatory bar than conventional diagnostic tools if users are to ingest it. Nevertheless, Google has employed 100 people from areas including astrophysics, chemistry and electrical engineering to work on the project. One radiology doctor advising the company says they are around five to seven years away from a product approved for use by doctors.
What are the drawbacks?
A pill that collects information from inside your body raises "maximum privacy concerns", says Tech Times. "Google is not exactly known for keeping its users' information private and was hugely criticised for handing over user information to US government agencies in previous years." Google insists it will not collect people's medical information or attempt to commercialise it, but simply license the technology to partners, enabling doctors and patients to use it as a medical device.
BBC health editor James Gallagher says Google will also have to address concerns around "false positives", when healthy people are told they are ill, as well as the issue of "over-diagnosis" when treatment is sometimes not needed despite a condition being discovered. "Screening the body for disease is littered with dangers," says Gallagher, "and if it is not done carefully, it could make hypochondriacs out of all of us."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'Helene's death toll surpasses 200'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Pig butchering: one of the world's fastest growing scams
In The Spotlight Beijing is cracking down on the crypto con but this has only pushed it worldwide
By Chas Newkey-Burden, The Week UK Published
-
Quiz of The Week: 28 September - 4 October
Have you been paying attention to The Week's news?
By The Week Staff Published
-
'Stunningly lifelike' AI podcasts are here
Under the Radar Users are amazed – and creators unnerved – by Google tool that generates human conversation from text in moments
By Abby Wilson Published
-
Will the Google antitrust ruling shake up the internet?
Today's Big Question And what does that mean for users?
By Joel Mathis, The Week US Published
-
Wall Street tumbles on poor tech results
Speed Read US markets had their worst day since 2022 as Tesla and AI stocks dropped
By Arion McNicoll, The Week UK Published
-
Why is the tech industry up in arms about Google's search algorithm leak?
Today's Big Question A leak of about 2,500 documents shed light on how Google's search engine operates, and not everyone is happy
By Justin Klawans, The Week US Published
-
How AI is going to change the Google search experience
Talking Points Summaries are the new links
By Joel Mathis, The Week US Published
-
Google unveils 'AI overviews' atop search results
Speed Read Users of the search engine in the US will now get AI-generated answers first
By Rafi Schwartz, The Week US Published
-
Perplexity AI: has Google finally met its match?
In The Spotlight Generative AI start-up provides fast, Wikipedia-like responses to search queries
By Chas Newkey-Burden, The Week UK Published
-
Artificial history
Opinion Google's AI tailored the past to fit modern mores, but only succeeded in erasing real historical crimes
By Theunis Bates Published